SCHEMBL27324701

SCHEMBL27324701

OCCC1CC2CCCCC2C1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.36
ALDH1A1 P00352 1/20 0.35
ESR2 Q92731 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20831170 0.81 ESR2 (0.38) ESR2
SCHEMBL10005780 0.78 ALDH1A1 (0.39) ALOX5ALDH1A1
SCHEMBL10771351 0.78 ESR2 (0.38) ESR2
SCHEMBL80485 0.77
SCHEMBL19824466 0.77 ALDH1A1 (0.40) ALOX5ALDH1A1ESR2
SCHEMBL15842180 0.76 BRD4 (0.36) ESR2
SCHEMBL15890454 0.75 ESR2 (0.34) ESR2
SCHEMBL25310751 0.75 CYP1A2 (0.48) ESR2
SCHEMBL21471 0.75
SCHEMBL16091690 0.75 CYP1A2 (0.48) ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619378-A2 IONIZABLE LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF NUCLEIC ACIDS Seawolf Therapeutics, Inc. (US) 2025-09-24 EP disclosed
CN-120202184-A Ionizable lipids and lipid nanoparticle compositions for delivery of nucleic acids 海狼治疗公司 2025-06-24 CN disclosed
WO-2024107906-A2 IONIZABLE LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF NUCLEIC ACIDS SEAWOLF THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed